Aciont gets $214K; Starpharma appoints exec;

> Aciont, based in Salt Lake City, has received $214,000 from the National Eye Institute and the National Institutes of Health to look into its ocular drug delivery system. Release

> Beginning in February 2011, Springer will launch a new peer-reviewed journal Drug Delivery and Translational Research, which will publish research on topics such as designing and developing novel drug delivery systems. Release

> Australia-based Starpharma has appointed Malcolm McColl to join the company's business development team as a vice president to meet the growing market demand for the company's dendrimer technology for drug delivery. Release

Suggested Articles

Zosano will need to run additional studies and await an FDA inspection to address the agency's complete response letter on its migraine patch Qtrypta.

Nanoform Finland tapped Quotient Sciences to help run the first in-human trial of a drug developed using its 'nanoforming' technology later this year.

Swiss scientists are using ultrasound to trap and deliver drugs in the brain, a non-invasive delivery method that could help target tumors, too.